Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Priority to UY27785ApriorityCriticalpatent/UY27785A1/en
Publication of UY27785A1publicationCriticalpatent/UY27785A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
La presente invención, se refiere a composiciones y procedimientos para el tratamiento de la obesidad. De una forma más particular, la invención, se refiere a una composición que comprende un inhibidor de lipasa, y konjac o glucomanan.The present invention relates to compositions and methods for the treatment of obesity. More particularly, the invention relates to a composition comprising a lipase inhibitor, and konjac or glucomanan.
UY27785A2003-04-282003-04-28
NEW PHARMACEUTICAL COMPOSITION
UY27785A1
(en)
Substituted 1,3-dihydro-5-isobenzofurancarbonitrile derivative compounds, selective serotonin reuptake inhibitors; pharmaceutical composition; preparation procedure; Useful in the treatment and / or prevention of premature ejaculation.
PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES